HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes

被引:39
作者
Romagnani, C
Pietra, G
Falco, M
Mazzarino, P
Moretta, L
Mingari, MC
机构
[1] Ist Giannina Gaslini, I-16147 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy
[4] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
[5] Ist Nazl Ric Canc, I-16132 Genoa, Italy
关键词
T cells; HLA-E; cytomegalovirus; UL40; alloreactivity;
D O I
10.1016/j.humimm.2004.02.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK)-cytotoxic T lymphocytes (CTL) are a subset of CD8(+) cytolytic T lymphocytes that express human leukocyte antigen (HLA) class I-specific inhibitory receptors. They are detectable as monoclonal expansions in the blood of cytomegalovirus (CMV)seropositive individuals displaying particular HLA-Cw allotypes. Similar to NK cells, they are capable of killing various allogeneic tumor cell lines, a function referred to as "NK-like activity." The mechanism underlying this unusual functional property has recently been clarified. Via their T-cell receptor, NK-CTL recognize the nonclassical HLA class I molecule HLA-E, which is characterized by a limited polymorphism and by the ability to bind peptides derived from the leader sequence of various HLA class I alleles as well as from few viral proteins. The analysis of the T-cell receptor avidity revealed that NK-CTL recognize with high avidity a CMV UL40-derived peptide. The HLA-E-restricted recognition of CMV by NK-CTL may represent an important immunologic strategy in defenses against this virus. Indeed, unlike conventional CTL, NK-CTL mediated lysis is apparently not affected by the downregulation of major histocompatibility complex class I that occurs during CMV infection. Because the CMV UL40-derived peptide is identical to the one generated from the leader sequence of various HLA-Cw alleles, NK-CTL are also able to display an "HLA-E- dependent alloreactivity" against allogeneic target cells expressing appropriate HLA-Cw alleles. This broad ability to recognize and kill allogeneic cells may pose serious problems in transplantation. Human Immunology 65, 437-445 (2004). (C) American Society for Histocompatibility and Immunogenetics, 2004. Published by Elsevier Inc.
引用
收藏
页码:437 / 445
页数:9
相关论文
共 40 条
[11]   Betaherpesviruses in transplant recipients [J].
Griffiths, PD ;
Clark, DA ;
Emery, VC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 :29-34
[12]   HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells [J].
Heinzel, AS ;
Grotzke, JE ;
Lines, RA ;
Lewinsohn, DA ;
McNabb, AL ;
Streblow, DN ;
Brand, VM ;
Grieser, HJ ;
Belisle, JT ;
Lewinsohn, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) :1473-1481
[13]  
Leach JL, 1996, J IMMUNOL, V157, P3317
[14]  
Lee N, 1998, J IMMUNOL, V160, P4951
[15]   HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A [J].
Lee, N ;
Llano, M ;
Carretero, M ;
Ishitani, A ;
Navarro, F ;
Lopez-Botet, M ;
Geraghty, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5199-5204
[16]   Induction of TCR Vβ-specific CD8+ CTLs by TCR Vβ-derived peptides bound to HLA-E [J].
Li, JF ;
Goldstein, I ;
Glickman-Nir, E ;
Jiang, H ;
Chess, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :3800-3808
[17]   Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens [J].
Lo, WF ;
Woods, AS ;
DeCloux, A ;
Cotter, RJ ;
Metcalf, ES ;
Soloski, MJ .
NATURE MEDICINE, 2000, 6 (02) :215-218
[18]  
Lo WF, 1999, J IMMUNOL, V162, P5398
[19]   Positive selection of an MHC class-I restricted TCR in the absence of classical MHC class I molecules [J].
Maurice, MM ;
Gould, DS ;
Carroll, J ;
Vugmeyster, Y ;
Ploegh, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7437-7442
[20]   A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition [J].
Michaëlsson, J ;
de Matos, CT ;
Achour, A ;
Lanier, LL ;
Kärre, K ;
Söderström, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) :1403-1414